- Potentially Treatable Condition
- Skin
- Wound
- HOME
- ABOUT
- RESEARCH
- INSIGHTS & HAPPENINGS
- JOIN US
- CONTACT US
-
Menu
Wound – A wound can be defined as damage to biological tissue, such as skin, mucous membranes, and organ tissues.
Wounds are traumas that cause the skin or other body tissues to rip open. They include skin punctures, cuts, scrapes, scratches, and so forth. Wounds are frequently the result of accidents, but they can also be brought on by surgery, sutures, or stitches.
Depending on how long a given wound takes to heal and how severe it is, there are various ways to categorise wounds.
Both open and closed wounds are possible. Open wounds, such as penetrating wounds, are wounds with exposed underlying tissue or organs that are accessible to the outside environment. Conversely, closed wounds are those that don’t allow any of the underlying tissue or organs to be exposed.
A wound can be categorised as acute or chronic based on how quickly it heals. Wounds that heal quickly and without complications are referred to as acute wounds.
Without correct first aid, some wounds can become easily infected. Signs of an infected wound are:
Depending on the hospital, doctor, and medical personnel, there are many forms of wounds and various treatment procedures (Figure 4). The majority of wound treatments are based on treating the wound. Modern wound dressings have been more popular recently, and they are frequently created in numerous forms with distinct advantages.
Additionally, their therapeutic uses may be constrained or ineffective due to issues such as a variety of available drugs, high cost, and a lack of standardized methods.
CelltiX is an extracted communicating vesicles derived from Umbilical Cord Derived Mesenchymal Stem Cells (MSCs). CelltiX is prepared in our state-of-the-art cGMP facility. Celltix is a new type of major paracrine factor released by MSCs into a culture medium playing an important function in a multitude of biological processes.
CelltiSS is a conditioned media formulated for topical administration to wound areas; used to treat and manage wounds and major skin loss. CelltiSS consists of various types of bioactive factors secreted by fibroblasts. The conditioned media is obtained from a cell culture collected at 80-90% confluency of the culture, which is the confluency at which the cells are in a mitotic phase, and there is maximum production of bioactive factors.
MyDerm® is an Autologous Bilayered Tissue Engineered Human Skin construct. The epidermal layer consists of 5 to 20 million keratinocytes embedded in a fibrin matrix developed by human plasma while the dermal layer consists of 5 to 20 million fibroblasts embedded in a fibrin matrix developed with human plasma.
K-Derm is an Autologous Single-Layered Tissue Engineered Human Skin construct made up of 5 to 20 million keratinocyte cells embedded in a fibrin matrix developed with human plasma. Not only does it cover up and heals wounds but it has the potential to save lives as it is not a type of dressing but rather acts as an organ transplant.
MyDerm® is an Autologous Bilayered Tissue Engineered Human Skin construct. The epidermal layer consists of 5 to 20 million keratinocytes embedded in a fibrin matrix developed by human plasma while the dermal layer consists of 5 to 20 million fibroblasts embedded in a fibrin matrix developed with human plasma.
FibroDerm is an Autologous Single-Layered Tissue Engineered Human Skin construct made up of 5 to 20 million fibroblast cells embedded in a fibrin matrix developed with human plasma. Not only does it cover up and heals wounds, but it has the potential to save lives as it is not a type of dressing but rather acts as an organ transplant.
ALGraft is an Allogenic Bilayered Tissue Engineered Human Skin construct. The epidermal layer consists of 1 to 2 million keratinocytes embedded in a fibrin matrix developed with human plasma while the dermal layer consists of 1 to 2 million fibroblasts embedded in a fibrin matrix developed with human plasma.
No side effects
Reducing scar formation
Reduces cell transplantation complication
No irritation
Improving the quality of wound healing
Economical and cost effective
Painless procedure
Reconstructing the structural and functional components of skin
No biopsy required
Accelerates healing
Reduce pain
Readily available
Avoids the need for surgery
Protect wound from infection or further damage
Minimal risk of injection
Promote tissue regeneration
Secrete growth factors, enzymes and biochemical to mimic the physiological activity of the skin
Lowering the size of wound
Encourage the repair of damaged growth factor signaling pathways
Restore the barrier function of damaged or burned skin
Secreting ECM proteins
Supply of crucial cytokines and chemokines
Promote rapid wound healing
Forming new collagen and extracellular matrix (ECM) structures
Supply of crucial cytokines and chemokines
Mimics the native skin layer of the epidermis
Accelerating wound healing and enhancing skin repair quality
If you feel we might be able to offer meaningful improvement to both your condition and your quality of life, then please reach out to schedule a free consultation with one of our in-house clinical experts. We offer consultations in both Malay and English.
Established in 2010, Cell Tissue is a Malaysian advanced medical technologybased company, a spin-off of the National University of Malaysia (UKM), one of the country’s leading universities and research institutes.
Cell Tissue is known as Malaysia’s FIRST Tissue Engineering Firm, awarded by the prestigious Malaysian Book of Records in 2016, operated in a certified Current Good Manufacturing Practice (cGMP) laboratory following PIC/S standards by the National Pharmaceutical Regulatory Agency (NPRA), a division of the Ministry of Health Malaysia.
Proudly powered by CTTSB © 2010-2024 Cell Tissue Technology Sdn Bhd, a Universiti Kebangsaan Malaysia spin-off Company. – All rights reserved.